ReviewMolecular cancer2020
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications.
Heng Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
158 papers cite itlatest 60 shown
this paperpooled ittrialcites it